By Holly Fernandez Lynch Well, hopefully we’ll know the fate of the ACA by tonight. But even if President Obama wins, there will still be uncertainty about the fate of the contraceptives coverage mandate. A number of employers claim that the mandate violates their rights to religious freedom by requiring them to offer free coverage…
Tuesday, November 13, 2012 12:30-2:00 Wasserstein Hall, Classroom 3019 Harvard Law School In the late 1940s, US and Guatemalan researchers conducted a host of experiments on vulnerable Guatemalan subjects, purposefully exposing them to and infecting them with a number of STDs without their consent. The experiments were kept hidden for more than half a century,…
By The Petrie-Flom Center The Department of Medical Ethics and Health Policy at the University of Pennsylvania Perelman School of Medicine invites applications for a new postdoctoral Fellowship in Advanced Biomedical Ethics, beginning in September 2013. The mission of this 2-year Fellowship is to train scholars and future leaders in academic biomedical ethics. Fellows will…
By Suzanne M. Rivera, Ph.D. I was giving a workshop presentation at the annual meeting of the National Council of University Research Administrators and my co-presenter raised an interesting idea. Tommy Coggins of the University of South Carolina was talking about the importance of integrity for preserving the public’s trust in the research enterprise, and…
TODAY! 12-1:30pm Austin Hall, Room 111 Harvard Law School On July 3, 2012, FDA approved OraQuick, the first at-home HIV test available for sale directly to consumers, allowing individuals to self-test and receive confidential results in about 20 minutes. Then on July 16, FDA approved once-daily Truvada, an already-approved HIV therapy, as the first agent approved for…
By Casey Thomson [Ed. Note: Several of our bloggers are active on Twitter. In a new feature, we’ll be posting some highlights of their tweets each week so you can stay in the know – or think about following them directly!] Dan Vorhaus (@genomicslawyer) linked to Bloomberg’s article on the current underutilization of…
By The Petrie-Flom Center Sorry for the delay – the Petrie-Flom Center co-hosted a fantastic conference today on institutional financial conflicts of interest in research universities, which kept me away from a computer all day. More to come on that, but without further ado, here is this week’s Yale Friday Newsletter, slightly modified for our…
By Arthur Caplan Weighing in on Question 2, Massachusetts’ ballot initiative on physician-assisted suicide, Art Caplan says we should vote “yes”: Mass. should legalize physician-assisted suicide Of the numerous ballot initiatives that will be decided at the state level on Tuesday, none is more hotly contested than the Massachusetts bill to decide whether to legalize physician-assisted…
By Katie Kraschel Mitt Romney’s anecdote about the binders of women he relied upon in selecting members of his cabinet when he was Governor has fueled criticism from feminist groups and filled my Facebook feed with a plethora of Halloween pictures featuring costumes depicting his unfortunate choice of words. People generally have an instinctive aversion to…
by Jonathan J. Darrow Until recently, most ordinary people had never heard of “pharmacy compounding.” Then, a number of deaths and illnesses caused by a drug that was compounded in a Framingham, Massachusetts pharmacy propelled drug compounding to the national spotlight (see, e.g., Denise Grady et al., Scant Oversight of Drug Maker in Fatal Meningitis…
